MiSight 1 Day contact lenses correct your child’s nearsightedness while simultaneously slowing it down. They’re the first and only soft contact lenses FDA-approved specifically to slow myopia progression in children, and they work by manipulating how light lands on the retina to send “slow down” signals to the growing eye.
The Dual-Focus Design
A standard single-vision contact lens has one job: bending all incoming light to a single focal point on the retina so your child sees clearly. It fixes blurry vision in the moment but does nothing to address the underlying problem, which is that the eyeball is growing too long from front to back.
MiSight lenses use what CooperVision calls ActivControl technology. The lens surface contains alternating rings that serve two different purposes. Some zones correct your child’s current prescription, just like a regular lens. The other zones are treatment zones that deliberately focus light slightly in front of the retina, creating what eye specialists call “myopic defocus” in the peripheral vision. Your child sees clearly through the correction zones while the treatment zones work in the background. Kids typically don’t notice the dual-focus effect during normal activities.
Why Peripheral Defocus Slows Eye Growth
When a child’s eye grows too long, light from distant objects focuses in front of the retina instead of directly on it, causing the blurry distance vision we call myopia. The problem tends to compound: as the eye elongates, the prescription gets stronger, and in many children the process keeps accelerating through the school years.
The retina responds to where light is focused relative to its surface. When the treatment zones in a MiSight lens place a focal point slightly in front of the peripheral retina, that signal travels through the tissue layers at the back of the eye. One key layer involved is the choroid, a blood-vessel-rich tissue sitting between the retina and the tough outer wall of the eye. Research published in Ophthalmology Science shows that the choroid thickens in response to myopic defocus, and this thickening happens quickly. A thicker choroid is associated with slower axial elongation, essentially putting the brakes on the eye’s lengthening. When myopia progresses unchecked, the opposite happens: the choroidal vessels thin and blood flow decreases.
This is a biological feedback loop. The defocus signal tells the eye it doesn’t need to keep growing, and the choroidal response is part of how that message gets translated into physical change at the structural level. Optical interventions like MiSight, orthokeratology lenses, and certain spectacle designs all exploit this same mechanism, though each delivers the defocus differently.
How Effective It Is
In the clinical trial that led to FDA approval, children wearing MiSight lenses experienced significantly less myopia progression compared to children wearing standard single-vision contact lenses. The lenses slowed axial length elongation, the physical stretching of the eyeball that drives worsening prescriptions, on a sustained basis over the study period. That distinction matters because some interventions show an initial slowdown that fades. MiSight showed continued slowing of eye growth over time on average.
The lenses don’t stop myopia progression entirely, and results vary from child to child. But even a partial reduction in how much the eye elongates during childhood can mean a meaningfully lower prescription in adulthood, along with reduced risk of the eye health problems that come with higher levels of myopia later in life.
Who Can Wear Them
The FDA approval covers a specific window. Children should be between 8 and 12 years old when they start treatment, with a prescription between -0.75 and -4.00 diopters and no more than 0.75 diopters of astigmatism. The eyes need to be otherwise healthy. Starting within this age range is important because it captures the years when myopia typically progresses fastest.
Children outside this prescription range or age window may still be candidates in some clinical settings, but the formal approval and the bulk of the evidence apply to that specific group. An eye care provider will measure your child’s refraction and eye length to determine whether MiSight is appropriate.
What Daily Wear Looks Like
MiSight lenses are daily disposables. Your child puts in a fresh pair each morning and throws them away at the end of the day. There’s no cleaning routine or storage case involved, which simplifies things for kids and reduces infection risk compared to reusable lenses.
For the lenses to work as intended, the wear schedule needs to be consistent. The recommendation from the clinical data is a minimum of 10 hours per day, at least 6 days per week. That typically means putting them in before school and wearing them through after-school activities. Children who wear them sporadically or for shorter stretches may not get the full myopia-slowing benefit.
How Long Treatment Lasts
This isn’t a short-term fix. Children generally wear MiSight lenses continuously until they reach their teenage years, when the rate of eye growth naturally slows and eventually stabilizes. For many kids, that means several years of daily wear. The American Academy of Ophthalmology notes that getting the full benefit requires maintaining the six-days-a-week, 10-hours-a-day schedule throughout this period.
Stopping treatment too early, while the eyes are still in a rapid growth phase, could allow myopia to resume progressing at its original pace. Your child’s eye care provider will track axial length and prescription changes over time to help determine when it’s reasonable to discontinue the lenses. Once eye growth has plateaued, the child can transition to standard contact lenses or glasses for simple vision correction.